Format

Send to

Choose Destination
BMC Immunol. 2015 Mar 26;16:12. doi: 10.1186/s12865-015-0074-3.

Human helminth therapy to treat inflammatory disorders - where do we stand?

Author information

1
Department of Immunology and Infection, Faculty of infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel street, London, WC1E 7HT, UK. helena.helmby@lshtm.ac.uk.

Abstract

Parasitic helminths have evolved together with the mammalian immune system over many millennia and as such they have become remarkably efficient modulators in order to promote their own survival. Their ability to alter and/or suppress immune responses could be beneficial to the host by helping control excessive inflammatory responses and animal models and pre-clinical trials have all suggested a beneficial effect of helminth infections on inflammatory bowel conditions, MS, asthma and atopy. Thus, helminth therapy has been suggested as a possible treatment method for autoimmune and other inflammatory disorders in humans.

PMID:
25884706
PMCID:
PMC4374592
DOI:
10.1186/s12865-015-0074-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center